News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LifeSpan BioSciences, Inc. And MBL International Corporation Announce Multi-Year Licensing And Asset Agreement



2/6/2006 11:09:59 AM

SEATTLE & WOBURN, Mass.--(BUSINESS WIRE)--Feb. 6, 2006--LifeSpan BioSciences, Inc. ("LifeSpan") and MBL International Corporation ("MBLI"), a wholly owned subsidiary of Medical and Biological Laboratories Co., Ltd. (Nagoya, Japan), announced today a multi-year relationship in which MBLI will distribute antibodies to druggable gene targets that LifeSpan has developed and commercialized. As part of the new relationship, MBLI has purchased LifeSpan's existing inventory of more than 900 antibodies including the exclusive research reagent sales rights. Financial terms of the transaction were not disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES